Survivor Story
When Karen's triple-negative breast cancer returned and spread, she advocated for herself. Today thanks to a clinical trial for immunotherapy, Karen has no evidence of disease.
Read Karen's Story
When Karen's triple-negative breast cancer returned and spread, she advocated for herself. Today thanks to a clinical trial for immunotherapy, Karen has no evidence of disease.
Read Karen's Story
Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.
Learn More
The AACR released the inaugural Cancer Disparities Progress Report, the first-of-its-kind publication providing a comprehensive overview of the latest research calling for health equity for all.
Read the Report
More than 55,000 people in the United States are diagnosed with pancreatic cancer each year.
Learn More
Learn about cancer researchers and physician-scientists like Fellow of the AACR Academy Charles L. Sawyers, MD, a leader in the development of targeted therapies, who are driving progress against cancer.
Learn More
The Week in Cancer News: A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.
Learn More
By including the American Association for Cancer Research in your legacy gift planning ensures a lasting impact on scientific discovery and innovation in the treatment and prevention of cancer for generations to come.
Learn More
The Call for Abstracts is now available for the AACR Annual Meeting, April 9-14, 2021, in Washington, DC.
Abstract Deadline: November 19
The American Association for Cancer Research (AACR) and our more than 47,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.
Learn MoreEva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.
Learn MoreA physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2018, to July 31, 2019
Learn MoreYour donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.
Donate Today